Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Share-based Compensation (2016 - 2025)

CV Sciences' Share-based Compensation history spans 12 years, with the latest figure at $124000.0 for Q3 2025.

  • For Q3 2025, Share-based Compensation rose 42.53% year-over-year to $124000.0; the TTM value through Sep 2025 reached $478000.0, up 155.61%, while the annual FY2024 figure was $258000.0, 18.35% up from the prior year.
  • Share-based Compensation for Q3 2025 was $124000.0 at CV Sciences, down from $132000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $912000.0 in Q2 2021 and bottomed at $30000.0 in Q1 2024.
  • The 5-year median for Share-based Compensation is $124000.0 (2025), against an average of $266789.5.
  • The largest annual shift saw Share-based Compensation plummeted 83.99% in 2022 before it skyrocketed 293.33% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $835000.0 in 2021, then plummeted by 79.64% to $170000.0 in 2022, then crashed by 80.59% to $33000.0 in 2023, then surged by 215.15% to $104000.0 in 2024, then rose by 19.23% to $124000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Share-based Compensation are $124000.0 (Q3 2025), $132000.0 (Q2 2025), and $118000.0 (Q1 2025).